Literature DB >> 27141295

Low-dose aripiprazole monotherapy in a young child with disruptive mood dysregulation disorder.

Roberto Averna1, Elisa D'Agati2, Stefano Vicari2.   

Abstract

Entities:  

Year:  2015        PMID： 27141295      PMCID： PMC4837963          DOI： 10.1177/2045125315591927

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  9 in total

1.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

Review 2.  Emotional modulation of control dilemmas: the role of positive affect, reward, and dopamine in cognitive stability and flexibility.

Authors:  Thomas Goschke; Annette Bolte
Journal:  Neuropsychologia       Date:  2014-07-25       Impact factor: 3.139

3.  DSM-5 disruptive mood dysregulation disorder: correlates and predictors in young children.

Authors:  L R Dougherty; V C Smith; S J Bufferd; G A Carlson; A Stringaris; E Leibenluft; D N Klein
Journal:  Psychol Med       Date:  2014-01-21       Impact factor: 7.723

4.  Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.

Authors:  E S Ercan; T Uysal; E Ercan; U Akyol Ardic; U A Ardıc
Journal:  Pharmacopsychiatry       Date:  2011-10-12       Impact factor: 5.788

5.  Cross-informant agreement of the Dysregulation Profile of the Child Behavior Checklist.

Authors:  Robert R Althoff; David C Rettew; Lynsay A Ayer; James J Hudziak
Journal:  Psychiatry Res       Date:  2010-05-26       Impact factor: 3.222

6.  Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Authors:  Randall Owen; Linmarie Sikich; Ronald N Marcus; Patricia Corey-Lisle; George Manos; Robert D McQuade; William H Carson; Robert L Findling
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

7.  Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder.

Authors:  William E Copeland; Adrian Angold; E Jane Costello; Helen Egger
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

8.  Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.

Authors:  David Mamo; Ariel Graff; Romina Mizrahi; C M Shammi; Françoise Romeyer; Shitij Kapur
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

9.  Neural mechanisms of frustration in chronically irritable children.

Authors:  Christen M Deveney; Megan E Connolly; Catherine T Haring; Brian L Bones; Richard C Reynolds; Pilyoung Kim; Daniel S Pine; Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2013-10       Impact factor: 18.112
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.